Vagally induced tachycardia in atropinized dogs: effect of beta-adrenergic blockade.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001949:Bretylium Compounds / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D010425:Pentolinium Tartrate / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology; D013268:Stimulation, Chemical; D013610:Tachycardia; D014630:Vagus Nerve / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D001949:Bretylium Compounds; D006584:Hexamethonium Compounds; D001285:Atropine; D010425:Pentolinium Tartrate; D011433:Propranolol; D013015:Sotalol; D011217:Practolol